Devices such as the investigational HeartNet™

Devices such as the investigational HeartNet™

Devices such as the investigational HeartNet™ system may hold promise for controlling or stopping heart enlargement and reducing the symptoms of heart failure.

If you''ve been diagnosed with heart failure (sometimes called HF, congestive heart failure or CHF), it means that your heart may be enlarged and can no longer pump blood efficiently throughout your body and to your vital organs. You may be experiencing symptoms that include chest pain, shortness of breath or swelling (edema) in your legs or ankles. Heart failure often leaves you feeling tired — and that constant fatigue may rob you of the ability to enjoy the little things in everyday life.

If you have heart failure, you may be eligible for a clinical research study.

The PEERLESS-HF clinical research study is currently underway in the United States and Canada to determine the safety and effectiveness of an investigational therapy called HeartNet. HeartNet is an implantable device that is placed around the heart and may help stop further enlargement and control the symptoms of heart failure.

If you (or someone you know) has heart failure, isn''t it worth a call to find out more and see if you might be eligible to participate in this study?

What is HeartNet?

HeartNet is a medical device made of a special Nitinol mesh that is placed permanently around both ventricles (the pumping chambers of the heart). It is designed to treat heart failure (also known as congestive heart failure, HF or CHF). HeartNet is investigational, meaning that the U.S. Food and Drug Administration (FDA) and other international regulatory bodies have given permission to test the device for safety and effectiveness. Safety and feasibility trials have already been completed in the United States and Europe, with results that support the advancement to a larger clinical research study.

How is HeartNet put on the heart?

HeartNet is placed around the heart in a less-invasive surgical inpatient procedure using a mini-thoracotomy or sternal sparing approach that avoids a sternotomy. It typically takes less than 90 minutes to complete.

How does HeartNet work?

HeartNet is designed to gently support the heart by placing a light "squeeze" on the ventricles, or pumping chambers, of the heart. HeartNet may control the heart''s enlargement, thereby allowing the heart to work more efficiently, decreasing HF symptoms such as fatigue, swelling of the legs and chest pain. If symptoms decrease, patients may begin to enjoy an improved quality of life and be able to return to their day-to-day activities.

Fill out the information to the right to see if you are eligible to participate in the PEERLESS-HF clinical research study.

Are you a candidate?

Fill in the form below and a research staff member will call you to determine if you qualify for the PEERLESS-HF clinical research study.

First Name:

Last Name:





I am between 18 and 74 years of age.

I have moderate HF (heart failure or congestive heart failure).

I am currently taking HF medication.

I''ve had HF for more than six months.

I have NOT HAD a heart bypass and I am not being considered for one in the near future.

By checking this box and hitting the Submit button, I agree to allow a representative to call me on the phone or email me to initiate the clinical trial screening process. I also agree to receive periodic information via email from

CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use. HeartNet is for investigational use only. HeartNet is a trademark of Paracor Medical, Inc.